(PDF) Arsenic Trioxide (ATO) and MEK1 Inhibition Synergize

Arsenic Trioxide (ATO) and MEK1 Inhibition Synergize to Induce Apoptosis in Acute Promyelocytic Leukemia Cells

Leukemia - United Kingdom

doi 10.1038/sj.leu.2403585

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

November 11, 2004

Authors

Publisher

Springer Science and Business Media LLC

Related search

‘Retinoic Acid and Arsenic Trioxide Sensitize Acute Promyelocytic Leukemia Cells to ER Stress’

Cancer Research

English

Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia

Cancer Research

English

Acute-Onset Hypokalemic Paralysis With Arsenic Trioxide Therapy in Patient With Acute Promyelocytic Leukemia

Journal of Community and Supportive Oncology

English

Pseudotumor Cerebri After Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide

Cancer Research

English

Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives

OncoTargets and Therapy

English

All-Trans Retinoic Acid and Arsenic Trioxide Fail to Derepress the Monocytic Differentiation Driver Irf8 in Acute Promyelocytic Leukemia Cells

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

PIC-1/SUMO-1-Modified PML-Retinoic Acid Receptor Α Mediates Arsenic Trioxide-Induced Apoptosis in Acute Promyelocytic Leukemia

Molecular and Cellular Biology

Molecular Biology

English

Systems Analysis of Transcriptome and Proteome in Retinoic Acid/Arsenic Trioxide-Induced Cell Differentiation/Apoptosis of Promyelocytic Leukemia

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Retinoid-Dependent Growth Inhibition, Differentiation and Apoptosis in Acute Promyelocytic Leukemia Cells. Expression and Activation of Caspases

Cell Death and Differentiation

Molecular Biology

English